Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 39

Sort by

Sort Order Select

Journal Articles

Revisiting acute chest syndrome (ACS) associated with sickle cell disease (SCD) vaso-occlusive pain episodes (VOE): Insight from a prospective, multicenter Phase-3 randomized controlled trial

Blood (2025) 146 (Supplement 1): 2946.

https://doi.org/10.1182/blood-2025-2946

Published: 2025

Journal Articles

Application of machine learning to identify risk factors for 14-day emergency department return visits in pediatric sickle cell patients discharged after vaso-occlusive crises

Kenneth McKinley, Muhammad Rahman, Deepika Darbari, Marius Linguraru, Syed Anwar, Andrew Campbell

Blood (2025) 146 (Supplement 1): 7893.

https://doi.org/10.1182/blood-2025-7893

Published: 2025

Journal Articles

Characterizing return-to-school after pain-related hospitalizations and hospital re-admission risk in pediatric sickle cell disease

Megan Connolly, Sydney Forman, Sara Ropeta, Andrew Campbell, Stephanie Merwin, Steven Hardy

Blood (2025) 146 (Supplement 1): 4451.

https://doi.org/10.1182/blood-2025-4451

Published: 2025

Journal Articles

Secretory phospholipase A2 (sPLA2) during vaso-occlusive pain episodes (VOE) and acute chest syndrome (ACS) in sickle cell disease (SCD): Results from a prospective multi-center randomized controlled trial (RCT)

Blood (2025) 146 (Supplement 1): 2923.

https://doi.org/10.1182/blood-2025-2923

Published: 2025

Journal Articles

Sickle cell disease treatment with arginine therapy (STArT) – results of a phase-3 randomized controlled trial

Blood (2025) 146 (Supplement 1): 616.

https://doi.org/10.1182/blood-2025-616

Published: 2025

Journal Articles

The psychometric properties of the stoplight pain scale in children with sickle cell disease

Blood (2025) 146 (Supplement 1): 4722.

https://doi.org/10.1182/blood-2025-4722

Published: 2025

Journal Articles

Impact of chronic pain on acute pain trajectories in sickle cell disease: Insights from the sickle cell disease treatment with arginine therapy (STArT) randomized controlled trial

Blood (2025) 146 (Supplement 1): 6524.

https://doi.org/10.1182/blood-2025-6524

Published: 2025

Journal Articles

A phase III, multicenter, randomized, placebo controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or without hydroxyurea/hydroxycarbamide therapy, in adolescent and adult sickle cell disease patients with frequent vaso-occlusive crises: The sparkle study

Andrew Campbell, Ana Silva-Pinto, Obiageli Nnodu, Deepa Manwani, Deborah Keefe, Jimmy Watson, Evgeniya Reshetnyak, Velusamy Muthusamy, Partha Banerjee, Olufolake Egbujo (Adisa), Michele Nassin, Yvonne Dei-Adomakoh

Blood (2025) 146 (Supplement 1): 1198.

https://doi.org/10.1182/blood-2025-1198

Published: 2025

Journal Articles

Sickle cell disease trials redefined: Toward unified clinical endpoints through international consensus

Mohamed Yassin, Nirmish Shah, Andrew Campbell, Salam Al-Kindi, Wally Smith, Charles Jonassaint, Miguel Abboud, Raffaella Colombatti, Dipty Jain, Halima Bello-Manga, Mariane de Montalembert, Ana Silva-Pinto, Steven Okoli, Abdelaziz Fahem, Biree Andemariam

Blood (2025) 146 (Supplement 1): 1166.

https://doi.org/10.1182/blood-2025-1166

Published: 2025

Journal Articles

Incidence and Risk Factors for Thrombosis in Cancer Patients with COVID-19

Alexander J. Didier, Andrew Campbell, Swamroop V Nandwani, Alan Fahoury, Camelia Arsene

Blood (2023) 142 (Supplement 1): 5527.

https://doi.org/10.1182/blood-2023-189704

Published: 2023

Journal Articles

Impact of Racial Disparities and Demographic Factors on Presentation, Treatment, and Survival Amongst Patients with Hodgkin Lymphoma

Alexander Didier, Ying Ning, Andrew Campbell, Danae M Hamouda

Blood (2022) 140 (Supplement 1): 8046–8047.

https://doi.org/10.1182/blood-2022-169477

Published: 2022

Journal Articles

The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice

Shuaiying Cui, Kim-Chew Lim, Lihong Shi, Mary Lee, Natee Jearawiriyapaisarn, Greggory Myers, Andrew Campbell, David Harro, Shigeki Iwase, Raymond C. Trievel, Angela Rivers, Joseph DeSimone, Donald Lavelle, Yogen Saunthararajah, James Douglas Engel

Blood (2015) 126 (3): 386–396.

https://doi.org/10.1182/blood-2015-02-626259

Published: 2015

Includes: Supplemental data

Journal Articles

Compound loss of function of nuclear receptors Tr2 and Tr4 leads to induction of murine embryonic β-type globin genes

Shuaiying Cui, Osamu Tanabe, Michael Sierant, Lihong Shi, Andrew Campbell, Kim-Chew Lim, James Douglas Engel

Blood (2015) 125 (9): 1477–1487.

https://doi.org/10.1182/blood-2014-10-605022

Published: 2015

Includes: Supplemental data

Journal Articles

Cardiopulmonary Functional Status in Children with SCD at Baseline: Pulse Pressure As a Biomarker of Early Compromise

Caterina P. Minniti, MD, Gregory J. Kato, MD, Mehdi Nouraie, MD PhD, Shoaib Alam, MD, Andrew Campbell, MD, Sohail R. Rana, MD, Deepika Darbari, MD, Oswaldo L Castro, MD, Victor R. Gordeuk, MD

Blood (2014) 124 (21): 2663.

https://doi.org/10.1182/blood.V124.21.2663.2663

Published: 2014

Journal Articles

Assessment of HbF QTLs Affecting Disease Severity and Genetic Analysis in Patients Homozygous for Codon 8 (–AA) β 0 -Thalassemia Mutation

Zhihua Jiang, PhD, Shengwen Huang, MD PhD, Hong Yuan Luo, MB, PhD, Nejat Akar, MD, A.Nazli Basak, MD, Nasir Al-Allawi, MD PhD, Sule Unal, MD, Fatma Gumruk, MDProf, Lance Davis, MD, Tasha Morrison, MPH,BA, Andrew Campbell, MD, Patrick G. Gallagher, MD, Bernard G Forget, MD, Martin H. Steinberg, MD, David H.K. Chui, MD

Blood (2014) 124 (21): 2690.

https://doi.org/10.1182/blood.V124.21.2690.2690

Published: 2014

Journal Articles

Sickle Cell Disease Proteinuria Is Not Associated With Systolic Blood Pressure, CSSCD-Defined Hypertension, or Family History Of Hypertension In An International Cohort Of SCD Patients

Andrew Campbell, MD, Biree Andemariam, MD, Fredericka Sey, MD, Connie M. Piccone, MD, Baba PD Inusa, MD, FRCPCH, Silverio Perrotta, MD, Imma Tartaglione, MD, William Zempsky, MD, Crawford John Strunk, MD, Rebekah Urbonya, Laura Sainati, MD, Adetola A. Kassim, MD, Charles Antwi-Boasiako, M.S., Deepa Manwani, M.D, Raffaella Colombatti, MD PhD

Blood (2013) 122 (21): 981.

https://doi.org/10.1182/blood.V122.21.981.981

Published: 2013

Journal Articles

Prediction of Fetal Hemoglobin in Sickle Cell Anemia Using a Genetic Risk Score

Jacqueline N Milton, MS, Paola Sebastiani, PhD, Clinton T. Baldwin, PhD, Efthymia Melista, Victor R. Gordeuk, MD, Mehdi Nouraie, PhD, Gregory J. Kato, M.D., Caterina Minniti, MD, James G. Taylor, M.D., Andrew Campbell, MD, Lori Luchtman-Jones, MD, Sohail R. Rana, MD, Oswaldo L Castro, MD, Yingze Zhang, PhD, Mark T Gladwin, MD, Martin H. Steinberg, MD

Blood (2012) 120 (21): 3216.

https://doi.org/10.1182/blood.V120.21.3216.3216

Published: 2012

Journal Articles

Improved Anemia, Organomegaly and Sustained Fetal Hemoglobin Induction within Aging TR2/TR4 Overexpressing UAB Sickle Cell Mice

Andrew Campbell, MD, Kori Bradley, Ama Amachong, Jennifer Addo, Rebekah Urbonya, Kwaku Osei Bonsu, David Harro, David Giacherio, Ph.D, Lihong Shi, PhD, Shuaiying Cui, Ph.D, Osamu Tanabe, MD, PhD

Blood (2012) 120 (21): 3248.

https://doi.org/10.1182/blood.V120.21.3248.3248

Published: 2012

Journal Articles

Genetic Determinants of Hemolysis in Sickle Cell Anemia.

Blood (2012) 120 (21): 2104.

https://doi.org/10.1182/blood.V120.21.2104.2104

Published: 2012

Journal Articles

Severe Impairment of γ-Globin Gene Silencing in an Asymptomatic Adult Patient Homozygous for the Codon 8 (–AA) Frame-Shift β 0 -Thalassemia Mutation

Andrew Campbell, MD, Hong-yuan Luo, Katherine Benson, Lance Davis, Patrick G. Gallagher, MD, Martin H. Steinberg, MD, Peter Fraser, PhD, Bernard G. Forget, MD, David H.K. Chui, MD

Blood (2012) 120 (21): 1022.

https://doi.org/10.1182/blood.V120.21.1022.1022

Published: 2012

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Revisiting acute chest syndrome (ACS) associated with sickle cell disease (SCD) vaso-occlusive pain episodes (VOE): Insight from a prospective, multicenter Phase-3 randomized controlled trial

Application of machine learning to identify risk factors for 14-day emergency department return visits in pediatric sickle cell patients discharged after vaso-occlusive crises

Characterizing return-to-school after pain-related hospitalizations and hospital re-admission risk in pediatric sickle cell disease

Secretory phospholipase A2 (sPLA2) during vaso-occlusive pain episodes (VOE) and acute chest syndrome (ACS) in sickle cell disease (SCD): Results from a prospective multi-center randomized controlled trial (RCT)

Sickle cell disease treatment with arginine therapy (STArT) – results of a phase-3 randomized controlled trial

The psychometric properties of the stoplight pain scale in children with sickle cell disease

Impact of chronic pain on acute pain trajectories in sickle cell disease: Insights from the sickle cell disease treatment with arginine therapy (STArT) randomized controlled trial

Sickle cell disease trials redefined: Toward unified clinical endpoints through international consensus

Incidence and Risk Factors for Thrombosis in Cancer Patients with COVID-19

Impact of Racial Disparities and Demographic Factors on Presentation, Treatment, and Survival Amongst Patients with Hodgkin Lymphoma

The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice

Compound loss of function of nuclear receptors Tr2 and Tr4 leads to induction of murine embryonic β-type globin genes

Cardiopulmonary Functional Status in Children with SCD at Baseline: Pulse Pressure As a Biomarker of Early Compromise

Assessment of HbF QTLs Affecting Disease Severity and Genetic Analysis in Patients Homozygous for Codon 8 (–AA) β 0 -Thalassemia Mutation

Sickle Cell Disease Proteinuria Is Not Associated With Systolic Blood Pressure, CSSCD-Defined Hypertension, or Family History Of Hypertension In An International Cohort Of SCD Patients

Prediction of Fetal Hemoglobin in Sickle Cell Anemia Using a Genetic Risk Score

Improved Anemia, Organomegaly and Sustained Fetal Hemoglobin Induction within Aging TR2/TR4 Overexpressing UAB Sickle Cell Mice

Genetic Determinants of Hemolysis in Sickle Cell Anemia.

Severe Impairment of γ-Globin Gene Silencing in an Asymptomatic Adult Patient Homozygous for the Codon 8 (–AA) Frame-Shift β 0 -Thalassemia Mutation

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only